Disease/Infection News

RSS

Healthcare systems seem may be ill-equipped to handle high co-circulation of influenza and SARS-CoV-2 in the coming year

In a new study, researchers conducted a community-based prospective cohort study in Managua, Nicaragua, before the winter season when influenza A (H3N2) cases surge in the Northern Hemisphere.

20 Sep 2022

What is the SARS-CoV-2 transmissibility among United States residents?

In a new study, researchers estimated region-specific basic reproduction number (R0) values for metropolitan statistical areas in the US, based on compartmental modeling with reproduced SARS-CoV-2 surveillance data.

20 Sep 2022

What are the 2-year health outcomes among patients hospitalized for COVID-19 in China?

A recent study assessed the dynamic trajectory of COVID-19 symptom burden as well as symptom persistence in those who survived SARS-CoV-2 infection for two years after being discharged from hospitals.

20 Sep 2022

Neutralizing antibody responses, breakthrough SARS-CoV-2 infections, and symptoms after booster BNT162b2 COVID-19 vaccinations

A new study evaluated neutralizing antibody (nAb) responses against the SARS-CoV-2 Omicron variant induced by booster vaccination with Pfizer-BioNTech’s BNT162b2 messenger ribonucleic acid vaccine.

20 Sep 2022

What are the effects of pesticides on neonates' health?

A new study explores the impact of pesticide exposure in neonates, reviewing current literature while evaluating the research methods used in this area.

20 Sep 2022

Regular fish oil consumption found effective in preventing severe COVID-19 outcomes

In a new study, researchers investigated whether regular fish oil use decreased the risk of contracting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

20 Sep 2022

New mechanistic insights on the origin of SARS-CoV-2-induced neurological disorders

Researchers explored the effect of SARS-CoV-2 exposure on the brain.

20 Sep 2022

The potential of nanobody engineering in the development of SARS-CoV-2 antivirals and diagnostic tools

Researchers investigated nanobody engineering to develop antivirals and diagnostic tools against SARS-CoV-2.

20 Sep 2022

Scientists find evidence of fungal organism Histoplasma capsulatum in Antarctica

...

20 Sep 2022

Monkeypox infection in a smallpox-vaccinated patient

In a recent study published in the Emerging Infectious Diseases journal, researchers at Madigan Army Medical Center assessed the characteristics of monkeypox infection in a patient vaccinated against smallpox.

20 Sep 2022

Endogenous exosomes act as decoys for SARS-CoV-2

A recent study published in the journal PLoS Biology discussed exosomes as potential decoys for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

20 Sep 2022

Coronavirus shedding by straw-colored fruit bats in Africa with potential for zoonotic pathogen transmission

In a recent study published in the journal PLoS ONE, researchers evaluated the temporal shedding patterns of coronavirus (CoV) in Eidolon helvum, the straw-colored fruit bat.

20 Sep 2022

In Denmark, Omicron reinfections reveal ineffective post-COVID-19 immunity

In a recent study posted to the medRxiv* preprint server, researchers investigated variant-wise SARS-CoV-2 reinfection cases in Denmark.

20 Sep 2022

Molecular engineered low-cost highly effective RBD-based COVID vaccine

In a recent study posted to the bioRxiv* preprint server, an international team of researchers developed a second-generation severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor binding domain (RBD) antigen (RBD-J6) by molecular engineering with two additional amino acid (aa) substitutions (S383D and L518D mutations) in a hydrophobic cryptic RBD core epitope to enhance stability and expression against SARS-CoV-2 variants of concern (VOCs).

19 Sep 2022

Study estimates 18 million Americans have long-COVID

In a recent study posted to the medRxiv* preprint server, researchers evaluated the prevalence, risk factors, and impact of post-coronavirus disease (COVID) conditions (PCC) or long COVID on daily activities among adults residing in the United States (US).

19 Sep 2022

O-linked sialoglycans affect SARS-CoV-2 spike cleavage

In a recent study posted to the bioRxiv* preprint server, researchers from Spain, the United Kingdom, and the United States used chemical tools to uncover the molecular details of glycan-mediated modulation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) processing.

19 Sep 2022

Environmental surveillance detects poliovirus type 2 outbreaks in Israel

The wastewater environmental surveillance conducted in Jerusalem, Israel, has detected an increasing population of poliovirus type 2. Furthermore, these viral isolates are associated with vaccine-derived viral strains.

19 Sep 2022

The predominant lineage in Europe of gonococcus is resistant to one of common drug treatments

A study featuring the participation of Fisabio (Foundation for the Promotion of Health and Biomedical Research of Valencia Region), dependent on the Conselleria de Sanitat Universal i Salut Pública, has found that the predominant lineage in Europe of gonococcus—the bacterium which causes gonorrhea—is resistant to one of the two drugs, among others, most commonly used today to treat this disease.

19 Sep 2022

United States joins 30 other countries with circulating vaccine-derived poliovirus

CDC today announced that polioviruses found in New York, both from the case of paralytic polio in an unvaccinated adult in Rockland County and in several wastewater samples from communities near the patient's residence, meet the World Health Organization (WHO)'s criteria for circulating vaccine-derived poliovirus (cVDPV) – meaning that poliovirus continues to be transmitted in Rockland County, NY, and surrounding areas.

19 Sep 2022

Pilot program intends to address inequities in accessing monkeypox vaccines

Today, local, state, and territorial health departments, as well as tribal governments and local non-governmental organizations, can partner together and begin submitting requests to access monkeypox vaccine through the recently announced Monkeypox Vaccine Equity Pilot Program.

19 Sep 2022

Disease/Infection News

Healthcare systems seem may be ill-equipped to handle high co-circulation of influenza and SARS-CoV-2 in the coming year

What is the SARS-CoV-2 transmissibility among United States residents?

What are the 2-year health outcomes among patients hospitalized for COVID-19 in China?

Neutralizing antibody responses, breakthrough SARS-CoV-2 infections, and symptoms after booster BNT162b2 COVID-19 vaccinations

What are the effects of pesticides on neonates' health?

Regular fish oil consumption found effective in preventing severe COVID-19 outcomes

New mechanistic insights on the origin of SARS-CoV-2-induced neurological disorders

The potential of nanobody engineering in the development of SARS-CoV-2 antivirals and diagnostic tools

Scientists find evidence of fungal organism Histoplasma capsulatum in Antarctica

Monkeypox infection in a smallpox-vaccinated patient

Endogenous exosomes act as decoys for SARS-CoV-2

Coronavirus shedding by straw-colored fruit bats in Africa with potential for zoonotic pathogen transmission

In Denmark, Omicron reinfections reveal ineffective post-COVID-19 immunity

Molecular engineered low-cost highly effective RBD-based COVID vaccine

Study estimates 18 million Americans have long-COVID

O-linked sialoglycans affect SARS-CoV-2 spike cleavage

Environmental surveillance detects poliovirus type 2 outbreaks in Israel

The predominant lineage in Europe of gonococcus is resistant to one of common drug treatments

United States joins 30 other countries with circulating vaccine-derived poliovirus

Pilot program intends to address inequities in accessing monkeypox vaccines

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News